| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 23.02. | HOTELES BESTPRICE: RELEVANT FACT Dividend Payment Notice | ||
| 23.02. | HOTELES BESTPRICE: Hoteles BESTPRICE launches a real estate investment vehicle of up to €60M for the acquisition and development of hotel assets | ||
| 23.02. | AIR LIQUIDE(L-): Share buyback | ||
| 23.02. | MEXEDIA S.P.A.: Mexedia Strengthens Financial Communication Governance and Announces the Launch of a Monthly Newsletter for Stakeholders | ||
| 23.02. | 2025 Annual report PostNL | ||
| 23.02. | POSTNL: Q4 & FY 2025 Results | ||
| 23.02. | JENSEN-GROUP: Share buy-back, weekly update | ||
| 20.02. | GROUPE SFPI: Liquidity agreement report S2 2025 | ||
| 20.02. | SONAE: Sonae SGPS, SA informs about refinancing of ESG-linked operations | ||
| 20.02. | PHOTONIKE CAPITAL: Photonike Capital SA Ordinary Shareholders Meeting approves FS2024 with 575.070 Euro Net Profit | ||
| 20.02. | TERACT S.A.: TERACT - Termination of liquidity agreement | ||
| 20.02. | PLASTICOS COMPUESTOS S.A. (KOMPUESTOS): Capital increase. | ||
| 20.02. | SAFRAN: Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026 | ||
| 20.02. | OPTION: REGULATED INFORMATION - Disclosure of a transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of major shareholdings) | ||
| 20.02. | GIMV: Announcement of share buyback in the context of a share purchase plan | ||
| 20.02. | AIR LIQUIDE(L-): 2025: With a record performance and confident in its transformation dynamic, Air Liquide confirms its growth outlook | ||
| 19.02. | BROADPEAK: Broadpeak publishes 2025 revenue | ||
| 19.02. | IMERYS: IMERYS_Press_Release_FY2025_ENG_19Feb2026_VF | ||
| 19.02. | Corticeira Amorim, SGPS, S.A. | 2025FY: Net profit of €56 million | ||
| 19.02. | LOUIS HACHETTE GROUP: Annual Results 2025 | ||
| 19.02. | LAGARDERE SA: Annual Results 2025 | ||
| 19.02. | SWI Capital Holding Ltd. lists on Euronext | ||
| 19.02. | ACCOR: Full-Year 2025 Results: Solid results above 2025 guidance | ||
| 19.02. | HYLORIS: Hyloris Provides Update on FDA Review of Valacyclovir for Oral Suspension | ||
| 19.02. | BE Semiconductor Industries N.V.: BE Semiconductor Industries N.V. Announces Q4-25 and Full Year 2025 Results |